Sepsis-Associated Encephalopathy: Review of the Neuropsychiatric Manifestations and Cognitive Outcome

被引：0
|
作者：
Lamar, Cory D. [1 ]
Hurley, Robin A. [2 ,3 ,4 ,5 ,6 ]
Taber, Katherine H. [2 ,3 ,7 ,8 ]
机构：
[1] Wake Forest Univ, Bowman Gray Sch Med, Dept Neurol, Winston Salem, NC 27103 USA
[2] WG Hefner Vet Affairs Med Ctr, Vet Affairs Mid Atlantic Mental Illness Res Educ, Salisbury, NC USA
[3] WG Hefner Vet Affairs Med Ctr, Res & Educ Serv Line, Salisbury, NC USA
[4] Wake Forest Univ, Bowman Gray Sch Med, Dept Psychiat, Winston Salem, NC USA
[5] Wake Forest Univ, Bowman Gray Sch Med, Dept Radiol, Winston Salem, NC USA
[6] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA
[7] Edward Via Coll Osteopath Med, Div Biomed Sci, Blacksburg, VA USA
[8] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA
来源：
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES | 2011年 / 23卷 / 03期
关键词：
INTENSIVE-CARE-UNIT; QUALITY-OF-LIFE; SEPTIC SHOCK; CECAL LIGATION; SURVIVORS; BRAIN; PATHOGENESIS; MORTALITY; DELIRIUM; ACETAZOLAMIDE;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：236 / 241
页数：6
相关论文
共 50 条
  • [41] Commentary on Posterior Reversible Encephalopathy Syndrome and Sepsis-Associated Encephalopathy
    Young, G. Bryan
    NEUROCRITICAL CARE, 2022, 37 (01) : 8 - 9
  • [42] Sepsis-Associated Encephalopathy: Insight into Injury and Pathogenesis
    Zhao, Lina
    Gao, Yanxia
    Guo, Shigong
    Lu, Xin
    Yu, Shiyuan
    Ge, Zeng Zheng
    Zhu, Hua Dong
    Li, Yi
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2021, 20 (02) : 112 - 124
  • [43] Role of Microglia in the Pathogenesis of Sepsis-Associated Encephalopathy
    Deng, Y. Y.
    Fang, M.
    Zhu, G. F.
    Zhou, Y.
    Zeng, H. K.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2013, 12 (06) : 720 - 725
  • [44] Sepsis-Associated Encephalopathy: From Delirium to Dementia?
    Chung, Ha-Yeun
    Wickel, Jonathan
    Brunkhorst, Frank M.
    Geis, Christian
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (03)
  • [45] Role of microRNAs As Biomarkers in Sepsis-Associated Encephalopathy
    Rebeca Osca-Verdegal
    Jesús Beltrán-García
    Federico V. Pallardó
    José Luis García-Giménez
    Molecular Neurobiology, 2021, 58 : 4682 - 4693
  • [46] Commentary on Posterior Reversible Encephalopathy Syndrome and Sepsis-Associated Encephalopathy
    G. Bryan Young
    Neurocritical Care, 2022, 37 : 8 - 9
  • [47] Research Progress of Biomarkers of Sepsis-Associated Encephalopathy
    ChengXin Tang
    WuShuang Zhou
    XiaoYing Chen
    FengLin Wang
    WenXian Men
    JingLun Liu
    Dan Zhang
    Intensive Care Research, 2023, 3 (1): : 69 - 76
  • [48] Potential of piperine for neuroprotection in sepsis-associated encephalopathy
    Ferreira, Flavia Monteiro
    Gomes, Sttefany Viana
    Carvalho, Luana Cristina Faria
    de Alcantara, Ana Carolina
    Castro, Maria Laura da Cruz
    Perucci, Luiza Oliveira
    Pio, Sirlaine
    Talvani, Andre
    Vieira, Paula Melo de Abreu
    Calsavara, Allan Jefferson Cruz
    Costa, Daniela Caldeira
    LIFE SCIENCES, 2024, 337
  • [49] Sepsis-associated encephalopathy: a vicious cycle of immunosuppression
    Chao Ren
    Ren-qi Yao
    Hui Zhang
    Yong-wen Feng
    Yong-ming Yao
    Journal of Neuroinflammation, 17
  • [50] Imaging in sepsis-associated encephalopathy—insights and opportunities
    Daniel J. Stubbs
    Adam K. Yamamoto
    David K. Menon
    Nature Reviews Neurology, 2013, 9 : 551 - 561
12345